Corcept Therapeutics Statistics
Total Valuation
LON:0I3Q has a market cap or net worth of GBP 5.63 billion. The enterprise value is 5.21 billion.
Market Cap | 5.63B |
Enterprise Value | 5.21B |
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 106.04M |
Shares Outstanding | n/a |
Shares Change (YoY) | +5.07% |
Shares Change (QoQ) | +1.15% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 87.67M |
Valuation Ratios
The trailing PE ratio is 54.90 and the forward PE ratio is 43.42.
PE Ratio | 54.90 |
Forward PE | 43.42 |
PS Ratio | 10.61 |
PB Ratio | 10.65 |
P/TBV Ratio | 10.65 |
P/FCF Ratio | 41.06 |
P/OCF Ratio | 40.54 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 61.81, with an EV/FCF ratio of 38.03.
EV / Earnings | 50.84 |
EV / Sales | 10.32 |
EV / EBITDA | 61.81 |
EV / EBIT | 64.08 |
EV / FCF | 38.03 |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.07 |
Quick Ratio | 2.69 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.06 |
Debt / FCF | 0.04 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 21.77% and return on invested capital (ROIC) is 11.14%.
Return on Equity (ROE) | 21.77% |
Return on Assets (ROA) | 9.18% |
Return on Invested Capital (ROIC) | 11.14% |
Return on Capital Employed (ROCE) | 15.69% |
Revenue Per Employee | 1.06M |
Profits Per Employee | 205,118 |
Employee Count | 500 |
Asset Turnover | 0.91 |
Inventory Turnover | 1.04 |
Taxes
In the past 12 months, LON:0I3Q has paid 1.64 million in taxes.
Income Tax | 1.64M |
Effective Tax Rate | 1.56% |
Stock Price Statistics
The stock price has increased by +130.77% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +130.77% |
50-Day Moving Average | 72.36 |
200-Day Moving Average | 61.31 |
Relative Strength Index (RSI) | 49.97 |
Average Volume (20 Days) | 453 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 8.59 |
Income Statement
In the last 12 months, LON:0I3Q had revenue of GBP 530.53 million and earned 102.56 million in profits. Earnings per share was 0.88.
Revenue | 530.53M |
Gross Profit | 521.82M |
Operating Income | 85.42M |
Pretax Income | 105.35M |
Net Income | 102.56M |
EBITDA | 86.17M |
EBIT | 85.42M |
Earnings Per Share (EPS) | 0.88 |
Balance Sheet
The company has 249.82 million in cash and 5.29 million in debt, giving a net cash position of 436.51 million.
Cash & Cash Equivalents | 249.82M |
Total Debt | 5.29M |
Net Cash | 436.51M |
Net Cash Per Share | n/a |
Equity (Book Value) | 528.86M |
Book Value Per Share | 4.99 |
Working Capital | 228.67M |
Cash Flow
In the last 12 months, operating cash flow was 138.88 million and capital expenditures -1.76 million, giving a free cash flow of 137.12 million.
Operating Cash Flow | 138.88M |
Capital Expenditures | -1.76M |
Free Cash Flow | 137.12M |
FCF Per Share | n/a |
Margins
Gross margin is 98.36%, with operating and profit margins of 16.10% and 19.55%.
Gross Margin | 98.36% |
Operating Margin | 16.10% |
Pretax Margin | 19.86% |
Profit Margin | 19.55% |
EBITDA Margin | 16.24% |
EBIT Margin | 16.10% |
FCF Margin | 25.85% |
Dividends & Yields
LON:0I3Q does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.07% |
Shareholder Yield | n/a |
Earnings Yield | 1.82% |
FCF Yield | 2.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LON:0I3Q has an Altman Z-Score of 19.46 and a Piotroski F-Score of 5.
Altman Z-Score | 19.46 |
Piotroski F-Score | 5 |